Special Issue "Polypeptides and Bioconjugates: Synthesis, Anticancer and/or Antimicrobial Activities"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biologics and Biosimilars".
Deadline for manuscript submissions: closed (13 September 2023) | Viewed by 234
Special Issue Editors
Interests: biologically active peptides; bioconjugates; the development of new methods for the determination of organic compounds in different matrices
Prof. Dr. Emilia Naydenova
Interests: biologically active peptides; unnatural amino acids; organic chemistry; synthesis and study of biologically active peptides
Special Issue Information
Dear Colleagues,
Many medicines on the pharmaceutical market are based on peptides or modified amino acids, such as enalapril (Vasotec), acetylcysteine (chemical name N-acetyl-L-cysteine), peptide antibiotics, as well as several analogues of the peptide hormone somatostatin, named octreotide, lanreotide, and vapreotide, which is used to fight different types of cancer. Therefore, peptides have been well proven as possible alternatives for other medical drugs in the treatment of different illnesses.
In recent years, many scientific groups have worked on the synthesis of bioconjugates between peptides and other chemical structures in their efforts to identify molecules with synergistic effects and improved pharmacodynamics.
Thus, this Special Issue aims to highlight and unite the scientific studies of different groups and the contemporary progress in the field of new peptide-based structures with anticancer and/or antimicrobial activities. Mathematical predictions may also be included, as well as investigations into prodrugs based on amino acids.
Prof. Dr. Dancho Danalev
Prof. Dr. Emilia Naydenova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- peptides and bioconjugates with anticancer activity
- peptides and bioconjugates with antimicrobial activity
- peptides and bioconjugates with both anticancer and antimicrobial activity
- prodrugs based on amino acids and peptides
- mathematical modeling and prediction of properties of peptide molecules with anticancer/antimicrobial properties
